• Health & Medicine

Over 2 million people in backlog for cancer care

Around 2.4 million people in the UK are waiting for cancer screening, further tests or cancer treatment according to a new analysis by Cancer Research UK. Around 2.4 million people in the UK are waiting for cancer screening, further tests or cancer treatment according to a new analysis by Cancer Research UK.

1 June 2020

• Health & Medicine

Immunotherapy for triple negative breast cancer approved for NHS in England 

Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer. Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer.

26 May 2020

• Health & Medicine

Breast and ovarian cancer drug effective in advanced prostate cancer

A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer. A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer.

1 May 2020

• Science & Technology

Pancreatic cancer cells use the same energy as sprinters’ muscles to spread

Our scientists are using hydrogels to understand more about how pancreatic cancer cells spread. Our scientists are using hydrogels to understand more about how pancreatic cancer cells spread.

26 March 2020

• Health & Medicine

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

26 March 2020

• Health & Medicine

Non-Hodgkin lymphoma treatment gets an initial ‘no’ for NHS use in England

A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England.  A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England. 

11 March 2020

• Science & Technology

Evolution, sex and TRACERx: how cancer’s ‘spare tyre’ helps it survive  

New research reveals how some cancer cells double their genome to help them survive. Find out more about cancer's 'spare tyre'. New research reveals how some cancer cells double their genome to help them survive. Find out more about cancer's 'spare tyre'.

5 March 2020

• Health & Medicine

‘Chemotherapy-free’ treatment for lymphoma made available for NHS use in England

New ‘chemotherapy-free’ treatment for follicular lymphoma approved for NHS use in England. New ‘chemotherapy-free’ treatment for follicular lymphoma approved for NHS use in England.

28 February 2020

• Science & Technology

Tracing the toxic fingerprint of a bacterium in our gut 

Our Grand Challenge scientists have discovered that a common type of bacteria found in our guts could contribute to bowel cancer. Our Grand Challenge scientists have discovered that a common type of bacteria found in our guts could contribute to bowel cancer.

27 February 2020

• Health & Medicine

Genetic 'fingerprints' implicate gut bacterium in bowel cancer

Grand Challenge researchers have found that a common type of bacteria found in our guts could contribute to bowel cancer. Grand Challenge researchers have found that a common type of bacteria found in our guts could contribute to bowel cancer.

27 February 2020

• Science & Technology

The making of a living ovarian cancer biobank

Our scientists are growing a living ovarian cancer biobank in Manchester. Our scientists are growing a living ovarian cancer biobank in Manchester.

20 February 2020

• Health & Medicine

Research suggests statins could lower ovarian cancer risk

A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer. A genetic study has found evidence to suggest that women who take statins in the long term could be less likely to develop ovarian cancer.

18 February 2020